FindTrial
Sign In

Effect of Ushiraadi anjana & Dwitiya Triphaladi ghrita pana in Timira(Presbyopia)

To study the effect of Ushiraadi anjana & Dwitiya Triphaladi ghrita pana in Timira(Presbyopia)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035591
Enrollment
40
Registered
2021-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H524- Presbyopia

Interventions

Intervention1: 1.Ushiraadi anjana for topical application. 2.Dwitiya Triphaladi ghrita for systemic administration( oral intake): 1.Topical application of Ushiraadi Anjana in conjunctival fornices fro

Sponsors

Rishikul campus Haridwar UAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with clinical features of Dwitiya patalagata timira(Presbyopia) 2. Patients between age group of 35-55 years 3. Patients having near visual acuity N6 with strain 4. Patient having distant vision 6/6 or best corrected distant vision

Exclusion criteria

Exclusion criteria: 1.Tritiya & Chaturtha patalagata Timira. 2.Patient with infective anterior segment disease & any other ocular pathologies like cataract, glaucoma & retinal pathologies. 3.Patients who have underwent any of the ocular surgeries 4.patients suffering from any of the systemic disorders (Hypertension, diabetes,dislipidemia)

Design outcomes

Primary

MeasureTime frame
Near vision improvementTimepoint: at 1st day, 25th day, 45th day—

Secondary

MeasureTime frame
Relief in other signs & symptoms of PresbyopiaTimepoint: 1st day , 25th day , 45th day—

Countries

India

Contacts

Public ContactDr Renu Prasad

Rishikul Campus, haridwar Uttarakhand Ayurved University

docrenuprasad@gmail.com9358826470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026